Abstract
The rise in the prevalence of autism spectrum disorder (ASD) has resulted in increased efforts to understand the causes of this complex set of disorders that emerge early in childhood. Although research in this area is underway and yielding useful, but complex information about ASD, guidelines for the use of genetic testing and counseling among children with ASD conflict. The purpose of this study was to determine the frequency of use of genetic testing and counseling before the widespread implementation of clinical chromosomal microarray (CMA) to establish a baseline for the use of both services and to investigate potential disparities in the use of both services among children with ASD. We found that about two-thirds of children with ASD received genetic testing or counseling and the use of both services is increasing with time, even in the pre-CMA era. Being female and having a comorbid intellectual disability diagnosis both increased the likelihood of receiving genetic testing and genetic counseling. Initial discrepancies in the use of both services based on race/ethnicity suggest that troubling disparities observed in other services delivered to children with ASD and other mental health disorders persist in genetic testing and counseling as well. These results should incentivize further investigation of the impact of genetic testing and counseling on children with ASD and their families, and should drive efforts to explore and confront disparities in the delivery of these services, particularly with the advancing scientific research on this topic.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abrahams BS, Geschwind DH (2008) Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 9(5):341–355
Alegria M, Vallas M et al (2010) Racial and ethnic disparities in pediatric mental health. Child Adolesc Psychiatr Clin N Am 19(4):759
American Academy of Pediatrics (2013). Initial medical evaluation of a child diagnosed with an autism spectrum disorders. Autism: caring for children with autism spectrum disorders: a resource toolkit for clinicians B. C. In: Hyman SL, Levy SE (eds). American Academy of Pediatrics, Elk Grove Village
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. Text Revision, Washington DC
Aratani Y, Cooper JL (2012) Racial and ethnic disparities in the continuation of community-based children’s mental health services. J Behav Health Serv Res 39(2):116–129
Caronna E, Milunsky J et al (2008) Autism spectrum disorders: clinical and research frontiers. Arch Dis Child 93:518–523
Chakrabarti S, Fombonne E (2001) Pervasive developmental disorders in preschool children. J Am Med Assoc 285(24):3093–3099
Constantino JN, Zhang Y et al (2010) Sibling recurrence and the genetic epidemiology of autism. Am J Psychiatry 167(11):1349–1356
Cooper GM, Coe BP et al (2011) A copy number variation morbidity map of developmental delay. Nat Genet 43(9):U838–U844
Coulter ME, Miller DT et al (2011) Chromosomal microarray testing influences medical management. Genet Med 13(9):770–776
Edwards A, Elwyn G (2001) Understanding risk and lessons for clinical risk communication about treatment preferences. Qual Health Care 10:i9–i13
El-Fishawy P, State M (2010) The genetics of autism: key issues, recent findings, and clinical implications. Psychiatr Clin North Am 33(1):83–105
Ellison JW, Ravnan JB et al (2012) Clinical utility of chromosomal microarray analysis. Pediatrics 130(5):E1085–E1095
Filipek PA, Accardo PJ et al (2000) Practice parameter: screening and diagnosis of autism—report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology 55(4):468–479
Folstein S, Rutter M (1977) Infantile autism: a genetic study of 21 twin pairs. J Child Psychol Psychiatry 18:297–321
Freitag CM, Staal W et al (2010) Genetics of autistic disorders: review and clinical implications. Eur J Child Adolesc Psychiatry 19(3):169–178
Girirajan S, Rosenfeld JA et al (2010) A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet 42(3):203–209
Gupta AR (2007) Recent advances in the genetics of autism. Biol Psychiatry 61(4):429–437
Hilton CL, Fitzgerald RT et al (2010) Brief report: under-representation of African Americans in autism genetic research: a rationale for inclusion of subjects representing diverse family structures. J Autism Dev Disord 40(5):633–639
International Molecular Genetic Study of Autism Consortium (IMGSAC) (2001) A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J Hum Genet 69(3):570–581
Johnson CP, Myers SM et al (2007) Identification and evaluation of children with autism spectrum disorders. Pediatrics 120(5):1183–1215
Kaminsky EB, Kaul V et al (2011) An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genet Med 13(9):777–784
Leblond CS, Heinrich J et al (2012) Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet 8(2):e1002521
Mandell DS, Novak M (2005) The role of culture in families’ treatment decisions for children with autism spectrum disorders. Ment Retard Dev Disabil Res Rev 11(2):110–115
Mandell D, Listerud J et al (2002) Race differences in the age at diagnosis among medicaid-eligible children with autism. J Am Acad Child Adolesc Psychiatry 41(12):1447–1453
Mandell DS, Ittenbach RF et al (2007) Disparities in diagnoses received prior to a diagnosis of autism spectrum disorder. J Autism Dev Disord 37(9):1795–1802
Mandell DS, Wiggins LD et al (2009) Racial/ethnic disparities in the identification of children With autism spectrum disorders. Am J Public Health 99(3):493–498
Mandell D, Morales K et al (2010a) County-level variation in the prevalence of medicaid-enrolled children with autism spectrum disorders. J Autism Dev Disord 40(10):1241–1246
Mandell DS, Morales KH et al (2010b) Age of diagnosis among medicaid-enrolled children with autism, 2001–2004. Psychiatr Serv 61(8):822–829
Manning M, Hudgins L et al (2010) Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 12(11):742–745
Maulik PK, Mascarenhas MN et al (2011) Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil 32(2):419–436
McGrew SG, Peters BR et al (2012) Diagnostic yield of chromosomal microarray analysis in an autism primary care practice: which guidelines to implement? J Autism Dev Disord 42(8):1582–1591
Mendelsohn NJ, Schaefer GB (2008) Genetic evaluation of autism. Semin Pediatr Neurol 15(1):27–31
Miller D (2010) Genetic testing for autism: recent advances and clinical implications. Expert Rev Mol Diagn 10(7):837–840
Miller DT, Adam MP et al (2010a) Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 86(5):749–764
Miller FA, Hayeems RZ et al (2010b) What is a meaningful result? Disclosing the results of genomic research in autism to research participants. Eur J Hum Genet 18(8):867–871
Muhle R, Trentacoste SV et al (2004) The genetics of autism. Pediatrics 113(5):E472–E486
Ozonoff S, Young GS et al (2011) Recurrence risk for autism spectrum disorders: a baby siblings research consortium study. Pediatrics 128(3):E488–E495
Regier DA, Friedman JM et al (2010) Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability. Am J Hum Genet 86(5):765–772
Roesser J (2011) Diagnostic yield of genetic testing in children diagnosed with autism spectrum disorders at a regional referral center. Clin Pediatr 50(9):834–843
Saam J, Gudgeon J et al (2008) How physicians use array comparative genomic hybridization results to guide patient management in children with developmental delay. Genet Med 10(3):181–186
Schaaf CP, Sabo A et al (2011) Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders. Hum Mol Genet 20(17):3366–3375
Schaefer GB, Mendelsohn NJ (2008a) Clinical genetics evaluation in identifying the etiology of autism spectrum disorders. Genet Med 10(4):301–305
Schaefer GB, Mendelsohn NJ (2008b) Genetics evaluation for the etiologic diagnosis of autism spectrum disorders. Genet Med 10(1):4–12
Semansky RM, Xie M et al (2011) Medicaid’s increasing role in treating youths with autism spectrum disorders. Psychiatr Serv 62(6):588
Shen YP, Dies KA et al (2010) Clinical genetic testing for patients with autism spectrum disorders. Pediatrics 125(4):E727–E735
Singer E, Antonucci T et al (2004) Racial and ethnic variation in knowledge and attitudes about genetic testing. Genet Test 8(1):31–43
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shea, L., Newschaffer, C.J., Xie, M. et al. Genetic testing and genetic counseling among medicaid-enrolled children with autism spectrum disorder in 2001 and 2007. Hum Genet 133, 111–116 (2014). https://doi.org/10.1007/s00439-013-1362-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-013-1362-8